Nutritional "omics" technologies for elucidating the role(s) of bioactive food components in colon cancer prevention

Journal of Nutrition

Volumn 135, Issue 11, 2005, Pages 2694-2697

  Davis, Cindy D ^a   Hord, Norman G ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Michigan State University   (United States)

Author keywords

Epigenetics; Metabolomics; Nutrigenetics; Nutrigenomics; Proteomics

Indexed keywords

PROTEIN;

CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CANCER; CONFERENCE PAPER; DNA METHYLATION; DNA POLYMORPHISM; DRUG ACTIVITY; FOOD COMPOSITION; GENE EXPRESSION; HUMAN; METABOLOMICS; MOLECULAR WEIGHT; NONHUMAN; NUTRITION; PROTEOMICS; TRANSCRIPTOMICS;

EID: 31544482723     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/135.11.2694     Document Type: Conference Paper

References (25)

1. Martinez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent Results Cancer Res. 2005;166:177-211.
2. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133:3731S-9.
3. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;10:66-88.
4. Bailey LB, Rampersaud GC, Kauwell GP. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr. 2003;133:1961S-8.
5. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132:2350S-5.
6. Livingston RJ, von Niederhausern A, Jegga AG, Crawford DC, Carlson CS, Rieder MJ, Gowrisankar S, Aronow BJ, Weiss RB, Nickerson DA. (2004) Pattern of sequence variation across 213 environmental response genes. Genome Res. 14:1821-31.
7. Molloy AM. Genetic variation and nutritional requirements. World Rev Nutr Diet. 2004;93:153-63.
8. Bailey LB, Gregory JF. Polymorphism of metheletetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr. 1999;129:919-22.
9. Chen J, Giovannucci EL, Hunter DJ. MTHFR polymorphism, methylreplete diets and the risk of colorectal carcinoma and adenoma among US men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr. 1999;129:560S-4.
10. Frost P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-3.
11. Margate T, Tsuji E, Kiyohara C, Eguchi H, Oda T, Shinchi K, Kono S. Relation of plasma folate and methyltetrahydrofolate reductase C677T polymorphism to colorectal adenomas. Int J Epidemiol. 2003;32:64-6.
12. Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, Yao K. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev. 2005;29:146-54.
13. Davis CD, Milner JA. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutation Res. 2004;551:51-64.
14. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa, JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141-96.
15. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415-28.
16. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 2002;21:5450-61.
17. Davis CD, Uthus EO. DNA methylation, cancer susceptibility and nutrient interactions. Exp Biol Med. 2004;229:988-95.
18. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr. 2002;132:2393S-400.
19. Crott JW, Choi WW, Ordovas JM, Ditelberg JS, Mason JB. Effects of dietary folate and aging on gene expression in the colonic mucosa of rats: implications for carcinogenesis. Carcinogenesis. 2004;25:69-76.
20. Ma DW, Finnell RH, Davidson LA, Callaway ES, Spiegelstein O, Piedrahita JA, Salbaum JM, Kappen C, Weeks BR, et al. Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res. 2005;65:887-97.
21. Wenzel U, Herzog A, Kuntz S, Daniel, H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004;4:2160-74.
22. Tan S, Seow TK, Linag RCMY, Koh S, Lee CPC, Chung MCM, Hooi SC. Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int J Cancer. 2002;98:523-31.
23. 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem. 2003;323:197-204.
24. Schatzkin, A. Problems with using biomarkers as surrogate end points for cancer: a cautionary tale. Recent Results Cancer Res. 2005;166:89-98.
25. Davis CD. Use of exfoliated cells from target tissues to predict responses to bioactive food components. J Nutr. 2003;133:1769-72.